It is a therapeutic monoclonal antibody that binds to the juxtamembrane region of human epidermal growth factor receptor-2 (HER2) and is successfully used in patients suffering from HER2-overexpressing breast cancer [22]. This evidence concerns the gene ERBB2 and breast carcinoma.